Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Site Injection Protocol of Intra-detrusor Onabotulinumtoxin-A for Treatment of Idiopathic Refractory Urgency Urinary Incontinence

NCT04731961 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04731961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Site Injection Protocol of Intra-detrusor Onabotulinumtoxin-A for Treatment of Idiopathic Refractory Urgency Urinary Incontinence
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 23, 2021
Completion date
February 28, 2027
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urgency urinary incontinence